Related Experiment Video

Updated: Apr 12, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K

The evolution of radiotherapy techniques in the management of prostate cancer

Morten Høyer1, Ludvig P Muren, Bengt Glimelius

  • 1Dept of Oncology, Aarhus University/Aarhus University Hospital , Aarhus , Denmark.

Acta Oncologica (Stockholm, Sweden)
|May 15, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.1K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.1K

Related Experiment Videos

Last Updated: Apr 12, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.1K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.1K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

10.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K

Articles linked to this work by shared authors, journal, and citation graph.

Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk.

Gut·2026

NTCP models predicting bowel toxicity after total neoadjuvant treatment or chemoradiation for rectal cancer in the RAPIDO trial.

International journal of radiation oncology, biology, physics·2026

Treatment of localized rectal cancer in the Nordic countries-comparison of Nordic to Dutch, ESMO, and NCCN guidelines.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2026

Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study.

The British journal of surgery·2026

Molecular-clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomas.

International journal of cancer·2026

Cost-effectiveness analysis of operative versus non-operative management of colorectal cancer metastases in the Finnish RAXO Study.

Acta oncologica (Stockholm, Sweden)·2026

Disparities in initiating standard first-line cancer treatment and survival for patients with an immigrant background: a Danish register-based cohort study.

Acta oncologica (Stockholm, Sweden)·2026

Fatigue 5 years after treatment for rectal cancer – results from the QoLiRECT study

Acta oncologica (Stockholm, Sweden)·2026

Association between CAR T-cell persistence and improved response to salvage radiotherapy in patients with DLBCL.

Acta oncologica (Stockholm, Sweden)·2026

Pre-operative circulating tumour DNA in high-risk primary cutaneous melanoma: prospective feasibility in molecular pathology.

Acta oncologica (Stockholm, Sweden)·2026

Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature.

Acta oncologica (Stockholm, Sweden)·2026

Interpreter use in Nordic paediatric oncology care - a multicentre cross-sectional study.

Acta oncologica (Stockholm, Sweden)·2026

Application of magnetic hyperthermia in prostate cancer treatment.

Acta of bioengineering and biomechanics·2026

Ultrasonography of the recurrent laryngeal nerve in thyroid cancer: advances in clinical application and research progress.

Frontiers in oncology·2026

Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges.

Frontiers in pharmacology·2026

Rectovaginal fistulas after radiation therapy: treatment options and outcomes - a narrative review.

Frontiers in oncology·2026

Radiation resistance is a property of long-lived plasma cells but not their precursors.

Immunotherapy advances·2026

Repeated romosozumab with short-term ibandronate sequencing in high-risk osteoporosis: a retrospective single-center cohort study.

JBMR plus·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us